Aberrant regulation of the Akt signaling network by human cytomegalovirus allows for targeting of infected monocytes.
Aberrant regulation of the Akt signaling network by human cytomegalovirus allows for targeting of infected monocytes.
复制标题
DOI:
10.1016/j.antiviral.2018.07.015
复制
发表时间:
2018-10
影响因子:
7.6
通讯作者:
Chan GC
中科院分区:
文献类型:
--
作者:
Peppenelli MA;Miller MJ;Altman AM;Cojohari O;Chan GC
Primary peripheral blood monocytes are responsible for the hematogenous dissemination of human cytomegalovirus (HCMV) following a primary infection. In order to facilitate viral spread, HCMV extends the naturally short 48-hour lifespan of monocytes by stimulating a non-canonical activation of Akt during viral entry, which leads to the increased expression of a specific subset of antiapoptotic proteins. In this study, global analysis of the Akt signaling network showed HCMV induced a more robust activation of the entire network when compared to normal myeloid growth factors. Furthermore, we found a unique interplay between HCMV-activated Akt and the stress response transcription heat shock factor 1 (HSF1) that allowed for the synthesis of both cap- and internal ribosome entry site (IRES)-containing antiapoptotic mRNAs such as myeloid cell leukemia-1 (Mcl-1) and X-linked inhibitor of apoptosis (XIAP), respectively. As generally a switch from cap-dependent to IRES-mediated translation occurs during cellular stress, the ability of HCMV to concurrently drive both types of translation produces a distinct milieu of prosurvival proteins needed for the viability of infected monocytes. Indeed, we found inhibition of XIAP led to death of ~99% of HCMV-infected monocytes while having minimal effect on the viability of uninfected cells. Taken together, these data indicate that the aberrant activation of the Akt network by HCMV induces the upregulation of a unique subset of antiapoptotic proteins specifically required for the survival of infected monocytes. Consequently, our study highlights the possibility of exploiting these virus-induced changes to prevent viral spread in immunocompromised patients at high-risk for HCMV exposure.
登录
查看更多内容
影响因子:
3.7
作者:
Chou SD;Prince T;Gong J;Calderwood SK
通讯作者:
Calderwood SK
影响因子:
3.7
作者:
Basu A;Sridharan S
通讯作者:
Sridharan S
影响因子:
56.9
作者:
Franke, TF;Kaplan, DR;Toker, A
通讯作者:
Toker, A
影响因子:
3.4
作者:
Emery, VC
通讯作者:
Emery, VC
DOI:
10.4049/jimmunol.0903025
发表时间:
2010-03-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Chan G;Nogalski MT;Bentz GL;Smith MS;Parmater A;Yurochko AD
通讯作者:
Yurochko AD